Asthma Phenotype with Metabolic Dysfunction
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Asthma is chronic eosinophilic bronchitis with the dominancy of T helper 2 (Th2) inflammation. However, patients with asthma and metabolic dysfunction have pathogenic and pathological differences from those with Th2 inflammation. Metabolic dysfunction, typically presented as metabolic syndrome, has several important clinical components including central obesity, insulin resistance or glucose intolerance, dyslipidemia, and vitamin D deficiency. Data from large epidemiological studies support the significance of these components in the control of asthma and their contribution to airway remodeling, suggesting the presence of an asthma phenotype with metabolic dysfunction. These components are quite interactive with each other, so it is difficult to reveal the individual role of each. It is well known that asthma is difficult to treat in patients with obesity, due in part to inadequate response to inhaled corticosteroids. Additionally, vitamin D deficiency and insulin resistance have been regarded as aggravating factors of asthma control and airway remodeling. Recent clinical and in vivo studies have revealed the specific mechanisms of these components, which may aggravate asthma control and airway remodeling. In this review article, I summarize the recent studies and unmet needs for patients with asthma and metabolic dysfunction.
Abstract
Asthma is chronic eosinophilic bronchitis with the dominancy of T helper 2 (Th2) inflammation. However, patients with asthma and metabolic dysfunction have pathogenic and pathological differences from those with Th2 inflammation. Metabolic dysfunction, typically presented as metabolic syndrome, has several important clinical components including central obesity, insulin resistance or glucose intolerance, dyslipidemia, and vitamin D deficiency. Data from large epidemiological studies support the significance of these components in the control of asthma and their contribution to airway remodeling, suggesting the presence of an asthma phenotype with metabolic dysfunction. These components are quite interactive with each other, so it is difficult to reveal the individual role of each. It is well known that asthma is difficult to treat in patients with obesity, due in part to inadequate response to inhaled corticosteroids. Additionally, vitamin D deficiency and insulin resistance have been regarded as aggravating factors of asthma control and airway remodeling. Recent clinical and in vivo studies have revealed the specific mechanisms of these components, which may aggravate asthma control and airway remodeling. In this review article, I summarize the recent studies and unmet needs for patients with asthma and metabolic dysfunction.
참고문헌 (83)
- Barnes PJ, "Harrison's principles of internal medicine", pp.1957~1969 (2018), McGraw-Hill Education
- "Global strategy for asthma management" (2020)[URL]
- Gupta S, "Qualitative analysis of high-resolution CT scans in severe asthma", Chest, 136, pp.1521~1528 (2009)
- Lee Sang Chul, "Long-Term Prognosis of Asthma-Bronchiectasis Overlapped Patients: A Nationwide Population-Based Cohort Study", Allergy, Asthma & Immunology Research, 13(6), pp.908~921 (2021), 대한천식알레르기학회[DOI]
- Uno S, "Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults : a claims-data analysis", BMC Pulm Med, 20, pp.262~ (2020)
- 박경희, "Single Center Experience of Five Diffuse Panbronchiolitis Patients Clinically Presenting as Severe Asthma", Journal of Korean Medical Science, 30(6), pp.823~828 (2015), 대한의학회
- Gibson PG, "Asthma-COPD overlap 2015 : now we are six", Thorax, 70, pp.683~691 (2015)
- Wenzel SE, "A randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma", Am J Respir Crit Care Med, 179, pp.549~558 (2009)
- Taillé C, "Monoclonal anti-TNF-α antibodies for severe steroiddependent asthma : a case series", Open Respir Med J, 7, pp.21~25 (2013)
- Busse WW, "Randomized, double-blind, placebo-controlled study of brodalumab, a human anti-IL-17 receptor monoclonal antibody, in moderate to severe asthma", Am J Respir Crit Care Med, 188, pp.1294~1302 (2013)
- Yang G, "Glycated hemoglobin A1c, lung function, and hospitalizations among adults with asthma", J Allergy Clin Immunol Pract, 8, pp.3409~3415 (2020)[DOI]
- Majak P, "Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection", J Allergy Clin Immunol, 127, pp.1294~1296 (2011)
- Peters MC, "Evidence for exacerbation-prone asthma and predictive biomarkers of exacerbation frequency", Am J Respir Crit Care Med, 202, pp.973~982 (2020)
- Beuther DA, "Overweight, obesity, and incident asthma : a meta-analysis of prospective epidemiologic studies", Am J Respir Crit Care Med, 175, pp.661~666 (2007)
- Permaul P, "Obesity may enhance the adverse effects of NO2 exposure in urban schools on asthma symptoms in children", J Allergy Clin Immunol, 146, pp.813~820 (2020)[DOI]
- Al-Alwan A, "The nonallergic asthma of obesity. A matter of distal lung compliance", Am J Respir Crit Care Med, 189, pp.1494~1502 (2014)
- Al-Alwan A, "The nonallergic asthma of obesity. A matter of distal lung compliance", Am J Respir Crit Care Med, 189, pp.1494~1502 (2014)
- Spivak H, "Weight loss and improvement of obesity-related illness in 500 U. S. patients following laparoscopic adjustable gastric banding procedure", Am J Surg, 189, pp.27~32 (2005)
- Macgregor AM, "Effect of surgically induced weight loss on asthma in the morbidly obese", Obes Surg, 3, pp.15~21 (1993)
- Schuliga M, "Trans forming growth factor-β-induced differentiation of airway smooth muscle cells is inhibited by fibroblast growth factor-2", Am J Respir Cell Mol Biol, 48, pp.346~353 (2013)
- Sideleva O, "Obesity and asthma : an inflammatory disease of adipose tissue not the airway", Am J Respir Crit Care Med, 186, pp.598~605 (2012)
- van Huisstede A, "Effect of bariatric surgery on asthma control, lung function and bronchial and systemic inflammation in morbidly obese subjects with asthma", Thorax, 70, pp.659~667 (2015)
- Kim JY, "Obesity increases airway hyperresponsiveness via the TNF-α pathway and treating obesity induces recovery", PLoS One, 10, pp.e0116540~ (2015)
- Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue", J Clin Invest, 112, pp.1796~1808 (2003)
- Mohamed-Ali V, "Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo", J Clin Endocrinol Metab, 82, pp.4196~4200 (1997)
- Bastard JP, "Evidence for a link between adipose tissue interleukin-6 content and serum C-reactive protein concentrations in obese subjects", Circulation, 99, pp.2221~2222 (1999)
- Eneli IU, "Weight loss and asthma : a systematic review", Thorax, 63, pp.671~676 (2007)
- Dietze J, "Obesity lowers the threshold of allergic sensitization and augments airway eosinophilia in a mouse model of asthma", Allergy, 67, pp.1519~1529 (2012)
- Vimaleswaran KS, "Causal relationship between obesity and vitamin D status : bidirectional Mendelian randomization analysis of multiple cohorts", PLoS Med, 10, pp.e1001383~ (2013)
- Wortsman J, "Decreased bioavailability of vitamin D in obesity", Am J Clin Nutr, 72, pp.690~693 (2000)
- Cardet JC, "Insulin resistance modifies the association between obesity and current asthma in adults", Eur Respir J, 48, pp.403~410 (2016)
- 박윤희, "Insulin resistance mediates high-fat diet-induced pulmonary fibrosis and airway hyperresponsiveness through the TGF-β1 pathway", Experimental and Molecular Medicine, 51, pp.1~12 (2019), 생화학분자생물학회[DOI]
- Han H, "Obesityinduced vitamin D deficiency contributes to lung fibrosis and airway hyperresponsiveness", Am J Respir Cell Mol Biol, 64, pp.357~367 (2021)
- Obesity. Preventing and managing the global epidemic : report of a WHO Consultation on Obesity, "World Health Organization", World Health Organization, ~ (1997)
- Japan Society for the Study of Obesity, "New criteria for ‘obesity disease’in Japan", Circ J, 66, pp.987~992 (2002)
- Yoshiike N, "Descriptive epidemiology of body mass index in Japanese adults in a representative sample from the National Nutrition Survey 1990-1994", Int J Obes Relat Metab Disord, 22, pp.684~687 (1998)
- Alberti KG, "Harmonizing the metabolic syndrome : a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity", Circulation, 120, pp.1640~1645 (2009)
- Ramirez AM, "Vitamin D inhibition of pro-fibrotic effects of transforming growth factor beta1 in lung fibroblasts and epithelial cells", J Steroid Biochem Mol Biol, 118, pp.142~150 (2010)
- Hewison M, "Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells", J Immunol, 170, pp.5382~5390 (2003)
- Searing DA, "Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use", J Allergy Clin Immunol, 125, pp.995~1000 (2010)
- Sutherland ER, "Vitamin D levels, lung function, and steroid response in adult asthma", Am J Respir Crit Care Med, 181, pp.699~704 (2010)
- Lehouck A, "High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease : a randomized trial", Ann Intern Med, 156, pp.105~114 (2012)
- Bergman P, "Vitamin D3 supplementation in patients with frequent respiratory tract infections : a randomised and double-blind intervention study", BMJ Open, 2, pp.e001663~ (2012)
- Saadoon A, "Effect of prenatal versus postnatal vitamin D deficiency on pulmonary structure and function in mice", Am J Respir Cell Mol Biol, 56, pp.383~392 (2017)
- Barrat FJ, "In vitro generation of interleukin 10-producing regulatory CD4(+)T cells is induced by immunosuppressive drugs and inhibited by T helper type 1(Th1)-and Th2-inducing cytokines", J Exp Med, 195, pp.603~616 (2002)
- Vasiliou JE, "Vitamin D deficiency induces Th2 skewing and eosinophilia in neonatal allergic airways disease", Allergy, 69, pp.1380~1389 (2014)
- Heulens N, "1, 25-dihydroxyvitamin D modulates antibacterial and inflammatory response in human cigarette smoke-exposed macrophages", PLoS One, 11, pp.e0160482~ (2016)
- Liu PT, "Cutting edge : vitamin Dmediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin", J Immunol, 179, pp.2060~2063 (2007)
- Forno E, "Effect of vitamin D3 supplementation on severe asthma exacerbations in children with asthma and low vitamin D levels : the VDKA randomized clinical trial", JAMA, 324, pp.752~760 (2020)
- Jolliffe DA, "Vitamin D supplementation to prevent asthma exacerbations : a systematic review and meta-analysis of individual participant data", Lancet Respir Med, 5, pp.881~890 (2017)
- Pfeffer PE, "Vitamin D in asthma : mechanisms of action and considerations for clinical trials", Chest, 153, pp.1229~1239 (2018)
- Pramyothin P, "Vitamin D in adipose tissue and serum 25-hydroxyvitamin D after roux-en-Y gastric bypass", Obesity(Silver Spring), 19, pp.2228~2234 (2011)
- Drincic A, "25-Hydroxyvitamin D response to graded vitamin D3 supplementation among obese adults", J Clin Endocrinol Metab, 98, pp.4845~4851 (2013)
- Roizen JD, "Obesity decreases hepatic 25-hydroxylase activity causing low serum 25-hydroxyvitamin D", J Bone Miner Res, 34, pp.1068~1073 (2019)
- Ojiaku CA, "Transforming growth factor β1function in airway remodeling and hyperresponsiveness. The missing link?", Am J Respir Cell Mol Biol, 56, pp.432~442 (2017)
- Zerr P, "Vitamin D receptor regulates TGF-β signalling in systemic sclerosis", Ann Rheum Dis, 74, pp.e20~ (2015)
- Tzilas V, "Vitamin D prevents experimental lung fibrosis and predicts survival in patients with idiopathic pulmonary fibrosis", Pulm Pharmacol Ther, 55, pp.17~24 (2019)
- Beilfuss A, "Vitamin D counteracts fibrogenic TGF-β signalling in human hepatic stellate cells both receptor-dependently and independently", Gut, 64, pp.791~799 (2015)
- Zhang H, "Vitamin D receptor targets hepatocyte nuclear factor 4α and mediates protective effects of vitamin D in nonalcoholic fatty liver disease", J Biol Chem, 295, pp.3891~3905 (2020)
- Abramovitch S, "Vitamin D inhibits proliferation and profibrotic marker expression in hepatic stellate cells and decreases thioacetamide-induced liver fibrosis in rats", Gut, 60, pp.1728~1737 (2011)
- Dong B, "Vitamin D receptor activation in liver macrophages ameliorates hepatic inflammation, steatosis, and insulin resistance in mice", Hepatology, 71, pp.1559~1574 (2020)
- 박정은, "Vitamin D and Metabolic Diseases: Growing Roles of Vitamin D", Journal of Obesity & Metabolic Syndrome, 27(4), pp.223~232 (2018), 대한비만학회
- Li YC, "Vitamin D : a negative endocrine regulator of the renin-angiotensin system and blood pressure", J Steroid Biochem Mol Biol (2004)
- Uhal BD, "Angiotensin signalling in pulmonary fibrosis", Int J Biochem Cell Biol, 44, pp.465~468 (2012)
- Shi Y, "Chronic vitamin D deficiency induces lung fibrosis through activation of the renin-angiotensin system", Sci Rep, 7, pp.3312~ (2017)
- Kumar R, "Putative roles of vitamin D in modulating immune response and immunopathology associated with COVID-19", Virus Res, 292, pp.198235~ (2021)
- Hyppönen E, "Hypovitaminosis D in British adults at age 45 y : nationwide cohort study of dietary and lifestyle predictors", Am J Clin Nutr, 85, pp.860~868 (2007)
- Pludowski P, "Vitamin D supplementation guidelines", J Steroid Biochem Mol Biol, 175, pp.125~135 (2018)
- Eckel RH, "The metabolic syndrome", Lancet, 365, pp.1415~1428 (2005)
- Baynes KC, "Vitamin D, glucose tolerance and insulinaemia in elderly men", Diabetologia, 40, pp.344~347 (1997)
- Leung PS, "The potential protective action of vitamin D in hepatic insulin resistance and pancreatic islet dysfunction in type 2 diabetes mellitus", Nutrients, 8, pp.147~ (2016)
- Norman AW, "Vitamin D deficiency inhibits pancreatic secretion of insulin", Science, 209, pp.823~825 (1980)
- Foer D, "Asthma exacerbations in patients with type 2 diabetes and asthma on glucagon-like peptide-1 receptor agonists", Am J Respir Crit Care Med, 203, pp.831~840 (2021)
- Nie Z, "Hyperinsulinemia potentiates airway responsiveness to parasympathetic nerve stimulation in obese rats", Am J Respir Cell Mol Biol, 51, pp.251~261 (2014)
- Dekkers BG, "Insulininduced laminin expression promotes a hypercontractile airway smooth muscle phenotype", Am J Respir Cell Mol Biol, 41, pp.494~504 (2009)
- Li CY, "Metformin use and asthma outcomes among patients with concurrent asthma and diabetes", Respirology, 21, pp.1210~1218 (2016)
- Wu TD, "Metformin use and risk of asthma exacerbation among asthma patients with glycemic dysfunction", J Allergy Clin Immunol Pract, 9, pp.4014~4020 (2021)[DOI]
- Calixto MC, "Metformin attenuates the exacerbation of the allergic eosinophilic inflammation in high fat-diet-induced obesity in mice", PLoS One, 8, pp.e76786~ (2013)
- Grill HJ, "A role for GLP-1 in treating hyperphagia and obesity", Endocrinology (2020)
- Daniel J. Drucker, "GLP-1 physiology informs the pharmacotherapy of obesity", Molecular Metabolism, 57, pp.101351~ (2022), Elsevier BV[DOI]
- Rogliani P, "Glucagon-like peptide 1 receptor : a novel pharmacological target for treating human bronchial hyperresponsiveness", Am J Respir Cell Mol Biol, 55, pp.804~814 (2016)
- Toki S, "Glucagon-like peptide-1 receptor agonist inhibits aeroallergen-induced activation of ILC2 and neutrophilic airway inflammation in obese mice", Allergy, 76, pp.3433~3445 (2021)
- Park HJ, "Empagliflozin and dulaglutide are effective against obesity-induced airway hyperresponsiveness and fibrosis in a murine model", Sci Rep, 9, pp.15601~ (2019)
